The vast majority of genetic diseases remains beyond possibilities of treatment with research continuing to be able to offer therapies to the affected patients.
Sandy Avrutin, Ocean and Earth Science Postgraduate Researcher, National Oceanography Centre at the University of Southampton, describes the uncertainty in sea-level rise, what it is & how we can use it as a tool.
Elize Sturkenboom – van de Wetering, Venture Leader of Lung Oncology at Phillips Healthcare, discusses the diagnosis and treatment of lung cancer through new minimally invasive therapy.
Optimising a drug’s ability to reach diseased body parts in adequate levels while avoiding healthy body parts – its tissue exposure and selectivity – is critical to therapeutic optimisation.
Tara M. DeSilva from the Department of Neurosciences, Cleveland Clinic, walks us through regenerative therapies for multiple sclerosis, including comment on clues from studying normal brain development.
Rob Irons, Senior Manager at Hinduja Global Solutions, discusses whether public sector customer service has improved with the adoption of cloud technology.
Eugene M. Terentjev, a professor of Polymer Physics at the University of Cambridge looks at smart, reusable adhesion through liquid crystalline elastomers.
One of JPND’s key objectives is to fortify its work in brain health partnerships in Europe to better combat the challenges of neurodegenerative disease (ND).
The majority of businesses supplying products and services into the NHS through surgical pathways cannot have failed to be aware of the declared intent by the NHS to decarbonise the health system.
